Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,252
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12612610 | Compositions and methods for controlling blood pressure | 🖼🧊📄§ | 2026-04-28 | 2042-11-11 | 0 | 31 |
| 12612628 | Composition for treating metastatic solid cancer, comprising TSG6 inhibitor | 🖼🧊📄§ | 2026-04-28 | 2041-06-16 | 0 | 31 |
| 12612631 | Small RNA medicament for prevention and treatment of inflammation-related diseases and combination thereof | 🖼🧊📄§ | 2026-04-28 | 2038-12-25 | 0 | 31 |
| 12610970 | Compositions for gut health | 🖼🧊📄§ | 2026-04-28 | 2040-08-14 | 0 | 31 |
| 12611401 | Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases | 🖼🧊📄§ | 2026-04-28 | 2040-05-15 | 0 | 31 |
| 12611438 | Antiviral composition comprising a nucleolin-binding peptide | 🖼🧊📄§ | 2026-04-28 | 2042-05-18 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611434 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | 🖼🧊📄§ | 2026-04-28 | 2043-06-21 | 0 | 31 |
| 12611445 | Interleukin-2 variants with modified biological activity | 🖼🧊📄§ | 2026-04-28 | 2040-03-27 | 0 | 31 |
| 12611448 | Targeting delivery system loaded with whole-cell components and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-05 | 0 | 31 |
| 12611396 | Microsphere-based injectible celecoxib formulation | 🖼🧊📄§ | 2026-04-28 | 2040-08-06 | 0 | 31 |
| 12611392 | Mitochondria-targeting antioxidants | 🖼🧊📄§ | 2026-04-28 | 2040-11-06 | 0 | 31 |
| 12611411 | Triple-agent therapy for cancer treatment | 🖼🧊📄§ | 2026-04-28 | 2042-09-15 | 0 | 31 |
| 12612402 | Nitrogen-containing fused heterocyclic compounds of n-sulfonamide and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-01-17 | 0 | 31 |
| 12611468 | Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma | 🖼🧊📄§ | 2026-04-28 | 2042-02-01 | 0 | 31 |
| 12612388 | Receptor-interacting protein 1 inhibitors including piperazine heterocyclic amide ureas | 🖼🧊📄§ | 2026-04-28 | 2041-05-20 | 0 | 31 |
| 12612399 | Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-10-12 | 0 | 31 |
| 12611461 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-04-28 | 2045-04-16 | 0 | 31 |
| 12611462 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-14 | 0 | 31 |
| 12612362 | Anisomycin derivative and use of anisomycin and derivative thereof as GLP-1R agonist | 🖼🧊📄§ | 2026-04-28 | 2043-07-24 | 0 | 31 |
| 12612427 | Aryl glucoside derivative, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12612392 | Compound, pharmaceutical compositions containing same, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-07-07 | 0 | 31 |
| 12612409 | Pyrrolopyrimidines as CFTR potentiators | 🖼🧊📄§ | 2026-04-28 | 2043-04-13 | 0 | 31 |
| 12612364 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | 🖼🧊📄§ | 2026-04-28 | 2045-12-03 | 0 | 31 |
| 12612374 | Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances | 🖼🧊📄§ | 2026-04-28 | 2040-09-10 | 0 | 31 |
| 12612453 | Method of treating glomerulonephritis by administering an antibody which binds and neutralizes human TGF-Beta1, TGF-Beta2 and TGF-Beta3 | 🖼🧊📄§ | 2026-04-28 | 2042-09-16 | 0 | 31 |
| 12612426 | Aryl glucoside derivative | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612448 | Tumor-targeting A56 protein or fragment thereof, antibody binding to A56 protein, and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-10-05 | 0 | 31 |
| 12612443 | Cell | 🖼🧊📄§ | 2026-04-28 | 2041-11-12 | 0 | 31 |
| 12611374 | Dermatological collar for non-human animals | 🖼🧊📄§ | 2026-04-28 | 2042-03-09 | 0 | 31 |
| 12611429 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2042-08-03 | 0 | 31 |
| 12611385 | Use of two-dimensional nanomaterial in inhibition of coronavirus | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12612343 | PSMA binder and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-04-13 | 0 | 31 |
| 12611408 | Methods for treating nail brittleness, fragility, or pitting | 🖼🧊📄§ | 2026-04-28 | 2039-06-04 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611467 | APOE gene therapy | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611454 | Recombinant vaccine against COVID-19 based on a paramyxovirus viral vector | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611419 | Liposomal composition for use in a method of treating Parkinson's disease | 🖼🧊📄§ | 2026-04-28 | 2043-03-09 | 0 | 31 |
| 12611432 | Immunostimulatory bacteria for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2043-07-11 | 0 | 31 |
| 12612390 | Modulators of methyl modifying enzymes, compositions and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-28 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12612384 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | 🖼🧊📄§ | 2026-04-28 | 2042-05-04 | 0 | 31 |